# Anika Therapeutics, Inc.: Form 8-K, filed May 28, 2024

- Company: [Anika Therapeutics, Inc.](/companies/anik.md) (CIK 898437)
- Form: 8-K
- Filed: 2024-05-28
- Accepted by EDGAR: May 28, 2024, 17:04 ET
- Period: 2024-05-28
- Accession: 0001171843-24-003136
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/898437/000117184324003136/f8k_052824.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/898437/000117184324003136/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/898437/000117184324003136/f8k_052824.htm

Filed May 28, 2024.
Source: SEC EDGAR, the filing index for accession 0001171843-24-003136. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.